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Lysophosphatidylcholine (LPC) is major component of plasma membrane. LPC is contained in plasma in micromolar concentrations (1-3) . LPC is an analogue of platelet activating factor (PAF) (4). Previous experiments have demonstrated that LPC is elevated in one-kidney-one-wrap hypertension in rabbits (5) and has natriuretic activity due to inhibition of renal tubular Na+-K+ ATPase (5-8). Some investigators suggest that LPC might act as a potent endothelium-dependent vascular relaxant (9-13). These reports suggest that LPC may be a humoral factor that promotes natriuresis and vasodilatation.
As for the mechanism by which LPC induces vasorelaxation, Saito et al. reported that such vasorelaxation was associated with a change in plasma membranous fluidity (11). A recent study has demonstrated that LPC (1O-~ M) rapidly evokes marked vasorelaxation of rat mesenteric artery with no change in plasma membranous fluidity (14) , suggesting the existence of a receptor-mediated vasorelaxation system involving LPC.
The exact mechanism of LPC-induced vasorelaxation remains unclear. In this study, we evaluated the roles of PAF receptor, endothelium-derived relaxing factor (EDRF, nitric oxide, NO), and prostaglandin systems in the mechanisms of endotheliumdependent vasorelaxation induced by LPC.
Materials and Methods
Five-to-eight-week-old male Sprague-Dawley rats (body weight, 250-350 g) were used in the experiments. After induction of anesthesia with pentobarbital sodium (50 mg/kg i.p.), the thoracic portion of the descending aorta (AO) and the first bifurcation of the superior mesenteric artery (SMA) were removed and immersed immediately in 37°C KrebsHenseleit buffer, containing (in mM) NaCI, 118.1 ; KCI, 4.7 ; CaC12, 2.5 ; KH2P04, 1.2 ; MgSO4, 1.2 ; NaHCO3, 25.0 ; and glucose, 11.0. AO and SMA were cut into rings about 3 mm in length. The diameter of the rings was 1.5 mm for AO and 0.8 mm for SMA. The endothelium was undenuded or denuded by inserting a teflon tube into the vascular lumen. Rings were mounted in a 20-ml organ chamber with both ends fastened. The chamber was carefully oxygenated with 95% 02 and 5% CO2 by slow bubbling to prevent foaming. The upper end of the ring was connected by a silk thread to a force displacement transducer (TB611T or TB612T, Nihon Koden, Tokyo). The initial tension was 2 g for AO and 1 g for SMA. Tension was induced by addition of phenylephrine (5 X 10-' M) to the organ chamber. After a steady state had been reached, the assigned doses of acetylcholine, LPC, or PAF were added to the organ chamber. The EDRF (NO) synthase inhibitor NG-monomethyl-L-arginine (LNMMA) (5 X 10-5 M), the PAF receptor antagonist CV-6209 (5 X 10-6 M), the cycloxygenase inhibitor indomethacin (10-5 M), or the guanylate cyclase inhibitor methylene blue (10-5 M) was added to the organ chamber 30 min before phenylephrine-induced contraction.
Reagents
Standard reagents were obtained from Sigma Chemical Company (St Louis, MO, USA), and LNMMA was obtained from Calbiochem Corporation (La Jolla, CA, USA). CV-6209 was a gift of Takeda Pharmaceutical Industries (Osaka, Japan). LPC, PAF (1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine), and CV-6209 were dissolved in water.
Statistical Analysis Data are expressed as means ± SEM. The data were analyzed by Student's t-test and one-way analysis of variance (ANOVA). After ANOVA, the statistical significance of differences between means Figure 1A shows that LPC significantly relaxed the unrubbed rings of aorta and mesenteric artery. No relaxation was found in the rubbed rings of aorta and mesenteric artery. The relaxation was dose-dependent, ranging from 5.9% with LPC (1O-~ M) to 44% with LPC (10-5 M) in the aortic rings. In the rings of mesenteric artery, the relaxation ranged from 17.3% with LPC (1O-~ M) to 37.6% with LPC (10-5 M) (Fig. 2) . Figures 1 and 2 show that the decrement in tension in unrubbed rings of aorta was less than that in mesenteric artery (p < 0.05); this difference was significant at the lower concentrations of LPC (1O-~ and 10-6 M). The relaxation with LPC (1O~' M) did not diminish after 1 h, suggesting no tachyphylactic effect (Fig. 1C) .
Results

Effect o f Lysophosphatidylcholine on Relaxation o f Aorta and Mesenteric Artery
Effect of NG-Monomethyl-L-Arginine on Relaxation Induced by Lysophosphatidylcholine
In the unrubbed preparations of mesenteric artery, pretreatment with LNMMA significantly reduced the percent relaxation induced by LPC (from 37.6% in control to 15.4%, p<0.05) (Fig. 1B, 2) . This attenuation of LPC-induced vasorelaxation by pretreatment with LNMMA was nearly abolished by additional treatment with L-arginine (10-5 M) (Fig.  1B) . L-arginine (10-5 M) caused a small but significant degree of endothelium-dependent relaxation in phenylephrine (5 X 10-~ M)-contracted mesenteric artery pretreated with LNMMA (5 X 10-5 M) (maximum relaxation = 5 ± 0.1%, p < 0.05, n = 3) (data not shown).
Effects of Indomethacin, Methylene Blue, and CV-6209 on Relaxation Induced by Lysophosphatidylcholine Indomethacin (10-5 M) did not prevent relaxation. Methylene blue (10-5 M) completely inhibited vasorelaxation. CV-6209 (5 X 10-6 M) also inhibited relaxation, from 37.6% in control to 8.6% (p < 0.01) in rat mesenteric artery and from 44.5% in control to 5.6% in rat aorta (p < 0.01) (Fig. 3, 4) . Effects of the inhibitors on LPC-induced vasorelaxation in unrubbed mesenteric artery are summarized in Fig. 5 .
Effect o f PAF on Relaxation o f Aorta and Mesenteric Artery PAF (1O-~ M) evoked 25% relaxation in the unrubbed aorta and transient 63% relaxation in the unrubbed mesenteric artery (Fig. 6A, 7) . The lowest concentration of PAF (10-9 M) evoked 8.0% relaxation in the unrubbed mesenteric artery, but did not relax the unrubbed aorta. One hour after an initial treatment with PAF, the same dose of PAF was added. The relaxation with PAF (10-6 M) was not attenuated 1 h later, suggesting no tachyphylactic effect. The relaxation with PAF (1O-~ M) was attenuated 1 h later (tachyphylaxis) (Fig. 8) .
Effect of LNMMA or CV 6209 on Relaxation Induced by PAF In the unrubbed mesenteric artery, pretreatment with LNMMA (5 X 10-5 M) significantly reduced the percent relaxation induced by PAF (10-5 M) from 86% to 43% (p < 0.05, Fig. 6B, 7A) . CV-6209 (5 X 10-6 M) also inhibited the percent relaxation induced by PAF (10-5 M) from 84% to 40% (p < 0.05, Fig. 7B, 8B ) in the unrubbed mesenteric artery.
Discussion
The mechanism of endothelium-dependent vasorelaxation evoked by LPC remains uncertain. Rees et al. showed that formation of EDRF was inhibited by LNMMA (15, 16) . However, it has not been reported whether LPC evokes nitric oxide production in rat mesenteric artery. In the present study, LNMMA inhibited endothelium-dependent relaxation induced by LPC. The inhibition induced by LNMMA was reversed by the NO precursor L-arginine. These results support the notion that LPC-induced vasorelaxation is related to endothelium-derived nitric oxide production. Since indomethacin treatment had no apparent effect on the relaxation induced by LPC, the cyclooxygenase pathway may not be involved in LPC-induced endothelium-derived vasorelaxation.
Saito et al. reported that LPC (10-5 M)-induced endothelium-dependent vasorelaxation in the rabbit aorta was associated with changes in membrane fluidity and Ca2+ mobilization. They reported that LPC-induced relaxation was slow-acting and that the greatest relaxation was associated with a long aliphatic chain. In our study, the LPC-induced vasorelaxation in rat aorta was also slow.
We could not distinguish endothelium-dependent vasorelaxation from spontaneous relaxation of the aorta and found it very difficult to study the mechanism of LPC-induced relaxation with the use of rat aortic rings. We previously reported that LPC (1O-~ M) rapidly and potently evoked vasorelaxation with no change in membrane fluidity in rat mesenteric artery (14) . We therefore mainly use mesenteric artery to investigate mechanisms responsible for vasorelaxation.
Studies have shown that the chemical structure and physical properties of LPC are similar to those of PAF (4), both substances dose-dependently inducing endothelium-related vasorelaxation. The PAF-induced vasorelaxation is similar to that induced by phosphatidylcholine or LPC in rat aortic rings (17, 18) . Chiba et al. reported that low physiological concentrations of PAF above 3 X 10-12 M, which do not affect membrane fluidity, induced the endothelium-dependent vasorelaxation only in Wistar-Kyoto rat mesenteric artery (19) .
Since this relaxation is inhibited by the PAF antagonist CV-3988 (19, 20) , they concluded that endothelium-dependent vasorelaxation induced by PAF may be mediated by PAF receptors. It has been proposed that PAF induces vasorelaxation through PAF receptors connected to Ca channels (21, 22) or through IP3 production involving G protein (23) . CV-6209 is a more specific PAF receptor antagonist (24) than CV-3988. The former blocks PAF receptors at 5 X 10-6 M with no detergent effect, and the latter blocks PAF receptors at 5 X 10-5 M with detergent or toxic effects on the endothelium. Therefore, we used CV-6209 to evaluate vasorelaxation induced by PAF or LPC.
Our study clearly demonstrated that endotheliumdependent vasorelaxation induced by LPC was strongly inhibited by CV-6209. We speculate that LPC-induced vasorelaxation may be related to receptor-mediated signal transduction involving PAF receptors.
Three possible mechanisms of LPC-induced vaso- To test these hypotheses, we compared the characteristics of vasorelaxation induced by LPC and PAF. The vasorelaxation induced by LPC was very gradual (requiring about 15 min for maximum dilatation) in aorta. It was very difficult to differentiate relaxation induced by LPC from spontaneous re- laxation of the aorta. We therefore mainly use rat mesenteric artery. PAF (10-' M)-induced vasorelaxation was transient and a tachyphylactic effect was observed in the rat mesenteric artery. LPC (1O-~ M)-induced vasorelaxation was not transient, and no tachyphylactic effect was observed in the rat mesenteric artery. These findings support the notion that LPC-induced vasorelaxation may be mediated through not only the PAF receptor pathway but also through another pathway blocked by CV-6209 in the rat mesenteric artery. Recent studies have shown that PAF is produced by endothelial cells and acts in an autocrine or paracrine manner (or both) (25) . We speculate that LPC itself stimulates both PAF receptors and LPC receptors, or that PAF itself produced in endothelial cells in response to LPC stimulates PAF receptors. With regard to post-LPC or PAF receptor transduction, minimal evidence was provided for this theory, except for an elevation of intracellular free Ca2+ in endothelial cells after receptor stimulation (21, 22) . Elevation of intracellular Ca2+ may evoke EDRF (NO) synthesis in endothelium cells. Further investigations are needed to define the mechanism of endothelium-dependent vasorelaxation induced by LPC.
In conclusion, these results suggest that LPC potently and rapidly evokes endothelium-dependent vasorelaxation involving increased nitric oxide production in rat mesenteric artery through not only the PAF receptor pathway but also through another pathway possibly blocked by CV-6209. 
